Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
J Immunother Cancer. 2019 Jun 25;7(1):160. doi: 10.1186/s40425-019-0634-9.
J Immunother Cancer. 2019.
PMID: 31238970
Free PMC article.